Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions
SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced today its selection as a winner of the 2024 Digital Health Hub Awards, hosted by The Digital Health Hub Foundation. Chief Executive Officer Rob Eno accepted the Rising Star award in the ‘Home Health Diagnostic’ category during the renowned HLTH global healthcare conference.
“One of the main challenges in cardiac care is helping patients get the care they need in a timelier manner to prevent worse outcomes or an increased risk of death. This award is a validation of our dedicated team’s hard work to deliver a simple way for patients to capture high-fidelity ECG signals wherever they are when symptoms occur to minimize any delays in care,” commented Mr. Eno.
The recognition highlights HeartBeam’s use of cutting-edge digital innovations to achieve its mission of unlocking a more personalized approach to cardiac care. HeartBeam’s groundbreaking vector-based technology captures the heart’s electrical signals from three dimensions to provide total heart intelligence. By leveraging AI to analyze the data-rich signals, the Company believes it will be able to unlock a more personalized approach to cardiac care for patients.
The Company’s first application of its vector-based technology is a cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG. The HeartBeam system is currently under review with the FDA. The Company has 13 issued US patents and 4 issued international patents supporting the underlying technology.
“The competition this year has been extraordinary, with thousands of submissions from groundbreaking companies worldwide,” said Mark H. Goldstein, Chairman and Founder of The Digital Health Hub Foundation. “We congratulate our winners whose innovations have truly impressed our esteemed panel of judges. The Digital Health Hub Foundation looks forward to witnessing the profound impact our champions continue to make in the healthcare space.”
The Digital Health Hub Foundation’s mission is to support the world’s most innovative healthcare companies in scaling and growing. Since 2017, the 30,000-member community has been dedicated to fostering innovation, including early-to-late-stage healthcare companies, industry providers, payors, mentors, and investors. The annual awards bring together the healthcare industry to celebrate and validate the best of the best in health technology.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. The Company holds 13 US and 4 international issued patents related to technology enablement.
For additional information, visit HeartBeam.com.
Forward-Looking Statements
All statements in this release that are not based on historical fact are “forward-looking statements.” While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024303708/en/
Investor Relations Contact:
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
[email protected]
www.mzgroup.us
Media Contact:
[email protected]
Source: HeartBeam, Inc.
Released October 24, 2024